P1613: SINGLE-CELL ANALYSIS FOLLOWING SARS-COV-2 MRNA VACCINE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

• E. Tranter,
• B. Obermayer-Wasserscheid,
• M.-L. Hütter-Krönke,
• C. Junkuhn,
• I.-W. Blau,
• G. L. Vuong,
• L. Bullinger,
• I.-K. Na

Affiliations

E. Tranter

1 Department of hematology, oncology and tumor immunology, Charité Universitaetsmedizin Berlin

B. Obermayer-Wasserscheid

3 Core Unit Bioinformatics – CUBI, Berliner Institut für Gesundheitsforschung in der Charité/Berlin Institute of Health at Charité (BIH)

M.-L. Hütter-Krönke

1 Department of hematology, oncology and tumor immunology, Charité Universitaetsmedizin Berlin

C. Junkuhn

4 Charité Universitaetsmedizin Berlin

I.-W. Blau

1 Department of hematology, oncology and tumor immunology, Charité Universitaetsmedizin Berlin

G. L. Vuong

1 Department of hematology, oncology and tumor immunology, Charité Universitaetsmedizin Berlin

L. Bullinger

1 Department of hematology, oncology and tumor immunology, Charité Universitaetsmedizin Berlin

I.-K. Na

1 Department of hematology, oncology and tumor immunology, Charité Universitaetsmedizin Berlin